We are building a national organization committed to providing best-in-class cancer patient care, bringing together experienced medical professionals from complementary disciplines working in tandem with state-of-the-art technologies.
We believe in delivering the most advanced, cost-effective cancer treatment results by leveraging technology, innovation, efficiency and the practical experience of our organization and professional network.
The state-of-the art technologies of stereotactic radiosurgery (SRS) and stereotactic ablative body radiotherapy (SABR) are core to our operations. We value the medical benefits, constant clinical and technology developments as well as the cost efficiency this modern modality allows.
SRS and SABR offer highly-precise, non-surgical cancer treatment options for anywhere in the body, without sacrificing patients’ quality of life.
Our goal at Capital Radiosurgery is to bring these technologies out of the hospital environment and into the communities that will benefit from access to these advanced treatment options.
By partnering with existing clinics as well as opening new operations, we are currently expanding our presence in Florida, Maryland, New York, and Colorado.
Our investment and partnering approach is flexible. We are not limited by any specific investment horizon. We seek to accommodate the preferences of the parties and individuals involved and we have a flexible approach to shareholding, with a preference for majority investments, but the flexibility to gain majority ownership over time.